Sentence examples for complementary evaluation of from inspiring English sources

Nevertheless, studies to evaluate the mechanism of the drug effect would benefit greatly from complementary evaluation of specific RNA transcripts in tissue that are both reproducible and have a wide dynamic range (i.e. 10-fold differences for Q-PCR).

The present work investigates a novel methodology based on complementary evaluation of UDC in marine environments by electrochemical impedance spectroscopy (EIS) and electrochemical noise (EN) analysis using Hilbert spectra.

For example, because the input data used in this study are usually available when building numerical groundwater models, modelers could use both methods in a complementary evaluation of the hydrogeological processes.

Here we just try to provide a complementary evaluation of these predictors based on a common disorder definition.

In addition, assessment of another sGC activator, A-350619, and complementary evaluation of an inhibitor of phosphodiesterase activity did not reveal the expected differences (Additional file 3: Figure S1B).

For these reasons, ROC curves alone are not suitable to give a complete picture on the actual performance of the connectivity estimation methods, thus, motivating the introduction of a complementary evaluation method: the PPC.

Radiology of disorders of thyroid, parathyroid glands and complementary evaluation with nuclear medicine techniques (BK).

The use of a quantitative and a qualitative approach in combination increases the opportunity for a complementary evaluation, which provides a better understanding of GSD-Y's potential to influence the process of improving glycaemic control and life skills than using either approach alone.

The following sections present the four complementary evaluation methods developed and tested in the course of the FP7 METRONOME project.

The European Committee for Proprietary Medicinal Products CPMPP) issued a temporary market suspension in January 2000 and asked for complementary benefit/risk evaluation of the product.

In June 1999, the European Committee for Proprietary Medicinal Products (CPMP, now the CHMP) adopted an Opinion recommending the temporary suspension of the Marketing Authorizations for sertindole and asked for a complementary benefit/risk evaluation of the product [ 12].